Skip to main content
Clinical Trials/ISRCTN51203558
ISRCTN51203558
Completed
Not Applicable

Quality of life assessment and patient acceptability of intermittent versus continuous sex hormone suppression as treatment for locally advanced or metastatic prostatic cancer

Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)0 sites200 target enrollmentSeptember 30, 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cancer: Prostate
Sponsor
Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
Enrollment
200
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 30, 2005
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)

Eligibility Criteria

Inclusion Criteria

  • 200 patients recruited from Urological Oncology Clinical who have had six months androgen blockade.

Exclusion Criteria

  • Not provided at time of registration

Outcomes

Primary Outcomes

Not specified

Similar Trials